Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Non-Current Assets: 2012-2025

Historic Other Non-Current Assets for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to $19.4 million.

  • Ptc Therapeutics' Other Non-Current Assets fell 23.28% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year decrease of 23.28%. This contributed to the annual value of $20.7 million for FY2024, which is 42.88% down from last year.
  • According to the latest figures from Q3 2025, Ptc Therapeutics' Other Non-Current Assets is $19.4 million, which was down 10.76% from $21.8 million recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Other Non-Current Assets peaked at $75.2 million during Q1 2021, and registered a low of $19.4 million during Q3 2025.
  • Its 3-year average for Other Non-Current Assets is $28.3 million, with a median of $24.5 million in 2024.
  • As far as peak fluctuations go, Ptc Therapeutics' Other Non-Current Assets soared by 133.56% in 2021, and later crashed by 48.73% in 2024.
  • Over the past 5 years, Ptc Therapeutics' Other Non-Current Assets (Quarterly) stood at $46.5 million in 2021, then increased by 4.48% to $48.6 million in 2022, then declined by 25.39% to $36.2 million in 2023, then crashed by 42.88% to $20.7 million in 2024, then declined by 23.28% to $19.4 million in 2025.
  • Its Other Non-Current Assets was $19.4 million in Q3 2025, compared to $21.8 million in Q2 2025 and $21.4 million in Q1 2025.